Abstract
Background: 7–hydroxy–14H–naphtho[2,3–a]phenothiazine–8,13–dione (AQATP) was synthesized by using iodobenzenediacetate as catalyst from 1,4–dihydroxyanthraquinone (1,4–AQ) which was isolated from Cassia tora seeds. Methods: They were then characterized by various spectral techniques. Single crystal X-ray diffraction studies revealed that AQATP crystallizes in orthorhombic space group. ADME Test was performed to determine pharmacokinetic parameter using MedChem designer software. The In silico docking studies were performed to find out the anticancer effect of 1,4–AQ and AQATP using iGEMDOCK software taking CK2 protein as the target. In silico anti-inflammatory study was also carried out by means of the same software taking COX–2 and LOX–5 enzymes as the targets. Results: It was found that the derivative exhibited more binding affinity than the parent compound for both anticancer and anti-inflammatory activities. In vitro anticancer activity in colon cancer cell lines, anti-inflammatory activity by denaturation, COX and LOX assay were performed on AQATP. Conclusion: Results from both computational and in vitro analysis suggest that structural modification of 1,4–AQ could be considered as a good strategy to obtain a lead molecule for drug discovery.
Keywords: Anticancer, anti-inflammatory, AQATP, cassia tora, docking studies, 1, 4–dihydroxyanthraquinone.
Drug Delivery Letters
Title:Synthesis, Single Crystal Study, in silico Analysis, in vitro Antiinflammatory and Anticancer Activities of 7-hydroxy-14H-naphtho[2,3- a]phenothiazine-8,13-dione
Volume: 5 Issue: 2
Author(s): Shiny P. Laila, Annette Fernandez, Arun Kumar, Viswanadhan S. Vishnu, Rema D. Krishnan, Archana P. Das and Ompallil Thomas
Affiliation:
Keywords: Anticancer, anti-inflammatory, AQATP, cassia tora, docking studies, 1, 4–dihydroxyanthraquinone.
Abstract: Background: 7–hydroxy–14H–naphtho[2,3–a]phenothiazine–8,13–dione (AQATP) was synthesized by using iodobenzenediacetate as catalyst from 1,4–dihydroxyanthraquinone (1,4–AQ) which was isolated from Cassia tora seeds. Methods: They were then characterized by various spectral techniques. Single crystal X-ray diffraction studies revealed that AQATP crystallizes in orthorhombic space group. ADME Test was performed to determine pharmacokinetic parameter using MedChem designer software. The In silico docking studies were performed to find out the anticancer effect of 1,4–AQ and AQATP using iGEMDOCK software taking CK2 protein as the target. In silico anti-inflammatory study was also carried out by means of the same software taking COX–2 and LOX–5 enzymes as the targets. Results: It was found that the derivative exhibited more binding affinity than the parent compound for both anticancer and anti-inflammatory activities. In vitro anticancer activity in colon cancer cell lines, anti-inflammatory activity by denaturation, COX and LOX assay were performed on AQATP. Conclusion: Results from both computational and in vitro analysis suggest that structural modification of 1,4–AQ could be considered as a good strategy to obtain a lead molecule for drug discovery.
Export Options
About this article
Cite this article as:
Laila P. Shiny, Fernandez Annette, Kumar Arun, Vishnu S. Viswanadhan, Krishnan D. Rema, Das P. Archana and Thomas Ompallil, Synthesis, Single Crystal Study, in silico Analysis, in vitro Antiinflammatory and Anticancer Activities of 7-hydroxy-14H-naphtho[2,3- a]phenothiazine-8,13-dione, Drug Delivery Letters 2015; 5 (2) . https://dx.doi.org/10.2174/221030310502151214165344
DOI https://dx.doi.org/10.2174/221030310502151214165344 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diagnosis of Diabetes in a Diabetic Patients Urine and Blood Using a Combination Electrode with a Ubiquitous Handheld Analyzer
Current Analytical Chemistry Novel Therapeutic Approaches in Limiting Oxidative Stress and Inflammation
Current Pharmaceutical Biotechnology A Novel Potential Reproductive Effects of Pterocarpus marsupium Methanolic Extract on Testosterone Propionate Induced Polycystic Ovary Syndrome in Female Albino Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A<sub>2</sub> (Lp-PLA<sub>2</sub>) Bound to LDL and HDL
Current Pharmaceutical Design Editorial (Thematic Issue: What's Behind the Sex Gap in Cardiovascular Mortality?)
Current Pharmaceutical Design Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities
Current Pharmaceutical Design Are Circulating Monocytes as Microglia Orthologues Appropriate Biomarker Targets for Neuronal Diseases? (Supplementry Table)
Central Nervous System Agents in Medicinal Chemistry Periodontitis, Endothelial Dysfunction and Atherosclerosis
Vascular Disease Prevention (Discontinued) Targeting Dopaminergic System for Treating Nicotine Dependence
Central Nervous System Agents in Medicinal Chemistry Effects of Tai Chi Exercise on Physical and Psychological Health of Older People
Current Aging Science Reverse Pharmacognosy: Another Way to Harness the Generosity of Nature
Current Pharmaceutical Design Nutritional and Therapeutic Potential of Spirulina
Current Pharmaceutical Biotechnology Contemporary Risk Assessment and Cardiovascular Outcomes in Peripheral Arterial Disease
Cardiovascular & Hematological Disorders-Drug Targets Inpatient Care of the HIV Infected Patient in the Highly Active Antiretroviral Therapy (HAART) Era
Current HIV Research Solving the Programmed/Non-Programmed Aging Conundrum
Current Aging Science Recent Developments on Coronary Microvasculopathy after Heart Transplantation:A New Target in the Therapy of Cardiac Allograft Vasculopathy
Current Vascular Pharmacology The Diagnosis of Large Airway Pathology and the Role of Rigid Bronchoscopy
Current Respiratory Medicine Reviews Lipids and Non-Cardiac Vascular Disease: A Lecture Overview
Current Vascular Pharmacology Sleep Duration as a Risk Factor for Cardiovascular Disease- a Review of the Recent Literature
Current Cardiology Reviews Acute Physical Stress Increases Serum Levels of Specific microRNAs
MicroRNA